info icon

Other and unspecified hereditary haemolytic anaemias

D3_HEREDHAEMOLYTICANAEMIAOTHERNAS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D58.8, D58.9
  • Hospital discharge: ICD-9 282[8-9]
  • Hospital discharge: ICD-8 28238|2829
  • Cause of death: ICD-10 D58.8, D58.9
  • Cause of death: ICD-9 282[8-9]
  • Cause of death: ICD-8 28238|2829

2 out of 7 registries used, show all original rules.

45

4. Check minimum number of events

None

45

5. Include endpoints

None

45

6. Filter based on genotype QC (FinnGen only)

45

Control definitions (FinnGen only)

Control exclude
D3_HAEMOLYTICANAEMIA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 479 252 219
Only index persons 345 180 165
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 33.78 40.10 25.76
Only index persons 28.09 32.83 22.91

-FinnGen-

Key figures

All Female Male
Number of individuals 45 34 11
Unadjusted period prevalence (%) 0.01 0.01 0.00
Median age at first event (years) 30.55 32.14 25.65

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
10
17.88
13.97
3.6
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
19
28
11.01
13.49
21.1
3.1
u/l
243.5
236.7
0.09
19
28
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
18
34
8.16
10.13
8.8
4.2
umol/l
7.2
4.6
1.44
18
26
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
12
23
6.75
6.41
3.6
4.7
g/l
0.2
0.2
0.12
12
23
(3021960) Folate [Moles/volume] in Serum or Plasma
18
73
3.44
3.71
2.2
1.6
nmol/l
21.6
24.0
0.29
18
62
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
6
9.16
2.82
8.8
1.0
u/l
53.4
6.1
—
5
6
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
22
117
2.72
2.69
2.4
2.0
pmol/l
84.4
103.2
1.34
13
61
(3018677) aPTT in Platelet poor plasma by Coagulation assay
12
47
3.12
2.51
5.0
3.4
s
32.3
30.1
0.74
12
47
(3024561) Albumin [Mass/volume] in Serum or Plasma
24
137
2.61
2.51
8.6
4.7
g/l
36.6
36.5
0.05
24
131
(3033658) Prothrombin time (PT) actual/Normal
18
90
2.67
2.44
12.4
4.2
%
79.1
91.6
0.81
18
90
(3024354) Oxygen [Partial pressure] in Venous blood
10
36
3.29
2.38
3.9
5.1
kpa
4.7
5.1
—
10
36
(40758558) Short blood count panel - Blood
19
101
2.53
2.25
13.7
7.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
8
25
3.66
2.22
4.6
6.8
mmol/l
10.6
7.3
—
8
25
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
7
20
3.94
2.15
7.1
5.2
%
86.4
101.5
—
7
20
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
10
5.47
2.13
1.0
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
10
5.47
2.13
1.0
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
10
39
3.01
2.08
4.3
5.0
kpa
6.1
5.7
—
10
39
(3000991) Gas panel - Venous blood
9
33
3.15
2.07
7.4
10.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
21
121
2.38
2.06
16.1
5.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
11
4.96
1.99
2.6
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
11
4.96
1.99
1.0
1.3
—
—
—
0
0
(3012544) pH of Venous blood
10
40
2.93
1.99
4.3
4.9
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
6
17
3.90
1.91
6.7
5.6
kpa
8.7
9.4
—
6
17
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
37
286
2.65
1.88
16.1
5.9
u/l
87.8
77.4
0.62
37
263
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
8
30
3.02
1.83
8.8
8.5
mmol/l
24.9
25.7
—
8
30
(3004588) Protein electrophoresis panel - Serum or Plasma
5
13
4.18
1.76
1.6
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
32
238
2.19
1.54
3.8
3.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
6
22
2.98
1.49
6.2
5.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
11
54
2.37
1.47
2.3
3.6
e6/l
3.0
3.4
—
5
32
(3018418) pH of Serum or Plasma
17
102
2.07
1.42
5.2
3.4
—
7.4
—
0
15
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
0
37
0.00
1.42
0.0
3.1
—
19.4
—
0
13
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
20
129
1.99
1.37
4.4
2.9
u/l
27.0
28.4
0.19
20
121
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
8
35
2.56
1.35
3.3
2.2
u/l
22.8
28.6
—
8
29
(3032080) INR in Blood by Coagulation assay
19
121
1.99
1.35
13.6
6.3
inr
1.4
1.2
—
7
45
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
8
38
2.34
1.26
2.1
1.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
5
19
2.83
1.25
5.2
6.5
mmol/l
25.4
24.7
—
5
19
(3022145) Colonoscopy Study observation
8
39
2.27
1.23
1.5
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
18
116
1.92
1.21
4.4
3.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
8
142
0.47
1.21
6.8
3.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
8
40
2.21
1.19
2.1
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
9
46
2.19
1.12
2.0
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
16
102
1.88
1.10
2.4
3.2
e6/l
0.1
0.1
—
10
79
(3002582) Erythrocytes [#/volume] in Urine
17
111
1.85
1.08
4.4
3.2
e6/l
11.7
76.6
0.73
11
88
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
0
32
0.00
0.99
0.0
2.5
—
0.7
—
0
17
(3022217) INR in Platelet poor plasma by Coagulation assay
6
30
2.15
0.91
35.7
15.3
—
1.2
—
0
5
(3017143) Hepatitis C virus Ab [Presence] in Serum
8
47
1.85
0.86
1.1
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
13
84
1.77
0.83
12.6
3.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
26
0.00
0.81
0.0
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
9
55
1.79
0.80
2.0
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
31
356
0.58
0.79
4.6
4.0
mmol/l
1.3
1.5
3.79
31
336
(36304419) Bacteria [Presence] in Urine
15
103
1.68
0.78
2.5
3.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
18
130
1.64
0.78
5.2
3.9
e6/l
18.6
97.4
1.13
11
95
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
24
187
1.61
0.76
8.9
3.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
7
40
1.89
0.75
1.4
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
25
2.12
0.75
1.2
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
26
2.03
0.73
1.4
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
6
100
0.54
0.73
7.5
3.2
—
—
—
0
0
(3002256) Pathology report gross observation
7
42
1.79
0.72
1.3
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
5
27
1.96
0.71
1.2
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
32
361
0.61
0.67
5.5
4.4
mmol/l
2.5
2.9
1.17
32
342
(40768797) Stomach Pathology biopsy report
8
50
1.73
0.66
1.6
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
29
1.81
0.66
1.4
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
21
257
0.66
0.63
5.7
4.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
6
99
0.55
0.60
2.0
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
19
147
1.51
0.59
2.5
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
11
150
0.65
0.53
4.4
2.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
12
88
1.50
0.46
12.2
2.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
8
59
1.43
0.44
6.4
1.5
ug/g
118.6
107.2
—
8
46
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
32
1.63
0.44
4.0
2.8
—
—
—
0
0
(3000492) Spirometry study
5
32
1.63
0.44
1.2
1.3
—
—
—
0
0
(3015736) pH of Urine
11
145
0.68
0.44
5.8
3.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
9
66
1.45
0.42
1.3
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
0
15
0.00
0.42
0.0
1.9
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
16
0.00
0.42
0.0
2.1
—
1.5
—
0
11
(1002224) Polysomnography panel
0
16
0.00
0.42
0.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
33
359
0.70
0.39
4.7
4.1
mmol/l
4.2
4.8
2.67
33
339
(3011397) Hemoglobin [Presence] in Urine by Test strip
6
88
0.63
0.37
3.8
3.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
16
131
1.34
0.33
6.8
3.1
ng/l
56.1
22.4
—
9
83
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
29
261
1.31
0.30
3.9
3.1
u/l
40.8
38.6
0.13
29
254
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
27
297
0.77
0.28
4.2
3.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
12
96
1.34
0.28
13.7
4.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
9
76
1.23
0.27
6.7
3.9
mg/mmol
4.0
5.3
—
9
46
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(4306422)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(4268621)
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
0
12
0.00
0.21
0.0
1.3
—
124.9
—
0
12
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.1
—
17.2
—
0
12
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.1
—
41.6
—
0
14
(3044640) Blood type and Crossmatch panel - Blood
14
120
1.24
0.19
11.5
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
65
0.74
0.18
1.2
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
13
115
1.18
0.12
1.8
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
61
0.80
0.09
1.0
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
7
79
0.87
0.08
7.3
3.3
—
1.0
—
0
8
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
9
87
1.04
0.07
1.6
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
10
103
0.96
0.00
2.3
3.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
97.8
—
0
9
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.8
—
0.6
—
0
5
(4027681)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
2.0
—
4.0
—
0
6
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
7.0
—
102.8
—
0
5
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
2.0
—
108.8
—
0
6
(3049717) Cytology report of Urine Cyto stain
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
8
82
0.97
0.00
1.6
1.8
—
—
—
0
0
(3013512) EKG study
8
87
0.90
0.00
1.5
3.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
5
0.00
0.00
0.0
4.0
—
5.1
—
0
5
(3051611) Lipemic interference index of Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
22.2
—
824.4
—
0
5
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
4.1
—
178.3
—
0
9
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
188.2
—
0
5
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
133.6
—
0
5
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
24.4
—
0
5
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
1.0
—
0
6
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint D3_HEREDHAEMOLYTICANAEMIAOTHERNAS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have D3_HEREDHAEMOLYTICANAEMIAOTHERNAS.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: D3_HEREDHAEMOLYTICANAEMIAOTHERNAS – Other and unspecified hereditary haemolytic anaemias

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data